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Summary
Phosducin-like proteins are conserved regulatory
components of G-protein signalling pathways, which
mediate many physiological processes. Identiﬁed
throughout eukaryotic genomes, they are thought to
serve as regulators of Gbg assembly. Cryphonectria
parasitica, a plant pathogen and causative agent of
chestnut blight, contains three Ga, one Gb, one Gg
subunits and phosducin-like protein BDM-1 that have
important roles in pigmentation, sporulation and
virulence. Deletion of either Gb subunit or BDM-1 pro-
duces identical phenotypes. Additionally, we report
that the Gb subunit is not detectable in absence of
BDM-1. Given that the regulatory role of phosducin-
like proteins may be inﬂuenced by protein kinase 2
(CK2), we conﬁrmed that BDM-1 is a phosphoprotein
that can be targeted by CK2 in vitro. Mutagenesis of
the ﬁve putative CK2 sites revealed that native phos-
phorylation likely occurs at two locations. Strains
bearing a single or double serine to alanine substitu-
tions at those sites were signiﬁcantly less virulent
with only minor phenotypic changes from vegetative
colonies. Therefore, CK2 activity appears to mediate
key signals that are required for virulence, but not
for vegetative growth. Expression of selected CK2
mutants resulted in reduced accumulation of the Gb
subunit, suggesting that phosphorylation of BDM-1
inﬂuences Gb stability.
Introduction
Heterotrimeric GTP-binding proteins (G-proteins), consist-
ing of three subunits Ga,G b and Gg, are ubiquitous sig-
nalling components that play a well established role in the
ability of eukaryotic organisms to react to environmental
stimuli (Cabrera-Vera et al., 2003). Functionally, the Ga
proteinisaGTP-asethatisactivewhenboundtoGTP.The
GbandGgsubunitsremainasatightlyboundcomplexthat
only modulate downstream effectors when separated from
the Ga partner. Upon activation by a transmembrane
receptor, Ga dissociates from Gbg, allowing both to inde-
pendently regulate downstream effectors. In complex
mammalian systems, G-proteins transduce a variety of
hormonal, neuronal and sensory signals that may affect
diverse outputs from cardiac rhythm to vision. In keeping
with this complexity, the three proteins that comprise the
heterotrimer (termed Ga,G b and Gg; Gilman, 1987) are
present in a variety of forms with as many as 20 Ga,5G b
and 12 Gg being reported (Mazzoni and Hamm, 2003).
Simpler eukaryotes, including Saccharomyces cerevi-
siae, Dictyostelium discoideum, and various ﬁlamentous
fungal systems have been shown to utilize the essential
features of this system, but with far fewer subunits. With
the advent of genome sequence information, it has been
possible to determine that Ascomycete fungal systems,
for instance, generally contain three Ga subunits, accom-
panied by a single representative each of Gb and Gg.
However, even with fewer subunits, the signalling pro-
cesses are still associated with the control of vital be-
haviours such as mating (S. cerevisiae; Dohlman et al.,
1998), morphogenesis and chemotaxis (D. discoideum;
Firtel and Chung, 2000), and asexual development (many
fungi; reviewed by Lengeler et al., (2000). Most impor-
tantly, G-protein signalling has also been found to be
essential for the virulence of many human and plant
pathogens, including Candida albicans (Maidan et al.,
2005a,b), Cryptococcus neoformans (Alspaugh et al.,
1997), Botrytis cinerea (Gronover et al., 2001),
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© 2010 Blackwell Publishing LtdMagnaporthe grisea (Liu and Dean, 1997), Ustilago
maydis (Regenfelder et al., 1997) and, the focus of this
study, Cryphonectria parasitica (Gao and Nuss, 1996).
Cryphonectria parasitica, a ﬁlamentous fungal plant
pathogen of the phylum Ascomycota, is the causative
agent of chestnut blight. First observed in the USA in the
early part of the 20th century (Merkel, 1906), the fungus
rapidly spread throughout the natural range of Castanea
dentata, the American chestnut, resulting in the near-
eradication of this species. However, hypovirulent strains
of C. parasitica were isolated (Grente, 1965) that were
subsequently shown to contain cytoplasmically transmiss-
able factors (Grente and Sauret, 1969). These were later
recognized as mycoviruses and placed in a new family, the
Hypoviridae(Hillmanet al.,1995).Intriguingly,correlations
have been noted between hypovirus-infected strains and
those for which G-protein signalling components have
been deleted. These correlations extend from phenotypic
observations (Gao and Nuss, 1996; Kasahara and Nuss,
1997) to expression-level analyses by microarrays (Dawe
et al., 2004) and suggested that contributions to the
hypovirus-infected phenotype of the fungal mycelium may
arise from a partially suppressed G-protein signalling
response (reviewed by Nuss, 2005).
Known modulators of the downstream signalling that
stems from the Gbg complex include the family of phos-
ducin and phosducin-like proteins (PhLPs). These have
been shown to be functionally related to Gbg complexes
in mammalian systems (Lee et al., 1987; Kuo et al.,
1989; Miles et al., 1993; Schulz, 2001), teleost ﬁsh
(Kobayashi et al., 2004), S. cerevisiae (Flanary et al.,
2000) and Dictyostelium discoideum (Knol et al., 2005).
In higher eukaryotes, this activity has been suggested
to negatively regulate the downstream effects of the
Gbg complex by sequestering these subunits (Schulz,
2001). In D. discoideum, however, a PhLP is essential
for proper Gbg dimer formation (Knol et al., 2005). In
C. parasitica, the deletion of bdm-1 results in a pheno-
type almost identical to that of a strain lacking the Gb
subunit CPGB-1 (Kasahara et al., 2000), suggesting that
BDM-1 is required for correct Gb function, and by infer-
ence, the Gbg complex. These lines of evidence point to
a positive regulatory function that has been supported by
evidence that PhLP is required the sequential assembly
of Gbg dimer in conjunction with cytosolic chaperonin
complex (CCT; Lukov et al., 2006). In this study, the
authors demonstrated that, for PhLP to perform this
function, it must be phosphorylated by protein kinase 2
(CK2). In the absence of this phosphorylation, proper
assembly of the Gbg complex is blocked.
In order to better understand the potential regulation of
Gbg activity through modulation by PhLP in fungi, we have
analysed the requirements for function of the BDM-1
protein from C. parasitica. We report that BDM-1 is a
phosphoprotein that can be a target for CK2 activity and
that this phosphorylation is functionally relevant. We have
observed that elimination of phosphorylation at these
sites caused a signiﬁcant reduction in virulence and the
quantity of both Gb and BDM-1 proteins, suggesting a role
for BDM-1 in protein stability that may be related to its
function in mammalian systems as a potential regulator of
the CCT complex (Lukov et al., 2005; 2006).
Results
BDM-1 is required for Gb subunit stability
To analyse the post-translational modiﬁcations of BDM-1
we have tagged the N-terminus of bdm-1 gene with FLAG
peptide using primers listed in Table 1. Resulting con-
structs were subcloned into the two different integrating
vectors listed in Table 2. pCPXNBn1 contained the con-
stitutive gpd promoter and pBC6HC1 the native bdm-1
promoter respectively. Integrated into the C. parasitica
Table 1. Oligonucleotide primers used in this study.
Primer Gene/function Oligonucleotide sequence 5′→3′
JS-10F BDM-1/m2Ala (S
55A) cagtaccgtgccgcaaagatcgacg
JS-12F BDM-1/m1Ala (S
45A) cgccagagacaacgctgacgacgaggag
JS-14F BDM-1/m3Ala (S
130A) gcgactccaagagcgctgactctgaagagc
JS-16F BDM-1/m4Ala (S
136A) actctgaagagcacgccggcgatgaggacg
JS-18F BDM-1/m5Ala (S
213A) gtctgaggtctgcgccctgatcgagtc
JS-20F BDM-1/m1Asp (S
45D) cgccagagacaacgatgacgacgaggag
JS-22F BDM-1/m2Asp (S
55D) cagtaccgtgccgacaagatcgacg
JS-24F BDM-1/m3Asp (S
130D) gcgactccaagagcgatgactctgaagagc
JS-26F BDM-1/m4Asp (S
136D) actctgaagagcacgacggcgatgaggacg
JS-28F BDM-1/m5Asp (S
213D) gtctgaggtctgcgacctgatcgagtc
5′-FLAG BDM-1/added FLAG at 5′ end gatggattacaaggatgacgacgataagtctaagactgccgcccaggaagaa
3′-HindIII BDM-1/added HindIII at 3′ end aaaagcttcagatgatgccgtggcgcagaa
JS-30F Gb/ added myc at 5′ end gatggaacaaaaactcatctcagaagaggatct
JS-31R Gb/ added HindIII at 3′ end aaaagcttctagtacgcccagattttgagcaat
JS-45R BDM-1/added XbaI at 3′ end ggtctagagcatgcgttaacaagcttca
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spheroplasts, both constructs rescued the distinct pheno-
type of Dbdm-1 (Fig. 1A). Western blot analysis conﬁrmed
the expression of the FLAG-BDM-1 protein (Fig. 1B). Total
protein extracts from recombinant strains expressing
FLAG-tagged BDM-1 were immunoprecipitated with
ANTI-FLAG M2-agarose beads and detected with anti-
FLAG, which demonstrated enrichment for FLAG-BDM-1
from total protein lysates (Fig. 1C).
We were able to detect the BDM-1 protein in DGb
lysates (Fig. 1B) but contrary to a previously published
observation (Kasahara et al., 2000), the Gb subunit was
absent from Dbdm-1 lysates of C. parasitica prepared
from liquid-grown mycelium (Fig. 1D) or from solid
medium (data not shown). The difference may be attrib-
utable to the use of an entirely different antiserum for the
experiments reported here. We have used a preparation
of the anti-CPGB-1 antiserum prepared subsequent to
the previous study, and one that was affinity puriﬁed using
recombinant CPGB-1. This preparation has been suc-
cessfully used to document changes in Gb accumulation
by Parsley et al. (2003) and Dawe et al. (2004) in both
solid and liquid medium.
BDM-1 is phosphoprotein and can be a target for CK2
activity in vitro
Post-translational modiﬁcation motifs were predicted by
PROSITE (http://ca.expasy.org/prosite/), which revealed
putative sites that included ﬁve for CK2, two for protein
kinase A (PKA), ﬁve for protein kinase C (PKC) and one
site for N-glycosylation (Fig. 2). To determine whether
there were any physiologically targeted phosphorylation
sites within the BDM-1 protein, we treated whole-cell
lysates with Calf Intestinal Alkaline Phosphatase (CIP) in
vitro (Fig. 3A). Based on previous reports describing
mammalian PhLP-1 as target for CK2 (Carter et al., 2004;
Lukov et al., 2005; 2006), we tested whether BDM-1 could
also be a potential substrate of CK2 phosphorylation.
By incubating BDM-1 bound to FLAG beads with protein
lysates from C. parasitica strain EP155 (WT), the migra-
tion pattern of BDM-1 was restored to that of BDM-1 prior
to CIP treatment (Fig. 3B). This process was inhibited by
the presence of 2-dimethylamino-4, 5, 6, 7-tetrabromo-
1H-benzimidazole (DMAT), the most potent and speciﬁc
CK2 inhibitor currently known (Pagano et al., 2004), indi-
cating that BDM-1 can be a target for CK2 activity in vitro.
Table 2. List of plasmids used in this study.
Plasmid Construct Description/mutation
pJS-2 pCR2.1-TOPO FLAG-Bdm-1
a FLAG-Bdm-1 in TOPO vector
pJS-2X pSC-A-amp/kan FLAG-Bdm-1
b FLAG-Bdm-1 in pSC-A vector
pJS-3 pCPXNBn1-FLAG-Bdm-1
c FLAG-Bdm-1 in expression vector (gpd promoter)
pJS-3X pBC6HC1- FLAG-Bdm-1
d FLAG-Bdm-1 in expression vector (native promoter)
pJS-4 pCR2.1-TOPO FLAG-Bdm-1 (S
45A)
c m1A
pJS-5 pCR2.1-TOPO FLAG-Bdm-1 (S
55A)
c m2A
pJS-6 pCR2.1-TOPO FLAG-Bdm-1 (S
130A)
c m3A
pJS-7 pCR2.1-TOPO FLAG-Bdm-1 (S
136A)
c m4A
pJS-8 pCR2.1-TOPO FLAG-Bdm-1 (S
213A)
c m5A
pJS-9 pCR2.1-TOPO FLAG-Bdm-1 (S
45,
136A)
c m14A
pJS-10 pCR2.1-TOPO FLAG-Bdm-1 (S
130,
136A)
c m34A
pJS-11 pCR2.1-TOPO FLAG-Bdm-1 (S
45,130,136A)
c m134A
pJS-12 pCR2.1-TOPO FLAG-Bdm-1 (S
45,55,130,136A)
c m1234A
pJS-13 pCR2.1-TOPO FLAG-Bdm-1 (S
45,55,130,136,213A)
c m12345A
pJS-14 pCR2.1-TOPO FLAG-Bdm-1 (S
45D)
c m1D
pJS-15 pCR2.1-TOPO FLAG-Bdm-1 (S
55D)
c m2D
pJS-16 pCR2.1-TOPO FLAG-Bdm-1 (S
130D)
c m3D
pJS-17 pCR2.1-TOPO FLAG-Bdm-1 (S
136D)
c m4D
pJS-18 pCR2.1-TOPO FLAG-Bdm-1 (S
213D)
c m5D
pJS-19 pCR2.1-TOPO FLAG-Bdm-1 (S
45,
136D)
c m14D
pJS-20 pCR2.1-TOPO FLAG-Bdm-1 (S
130,S
136D)
c m34D
pJS-21 pCR2.1-TOPO FLAG-Bdm-1 (S
45,130,136D)
c m134D
pJS-22 pCR2.1-TOPO FLAG-Bdm-1 (S
45,55,130,136D)
c m1234D
pJS-23 pCR2.1-TOPO FLAG-Bdm-1 (S
45,55,130,136,213D)
c m12345D
pJS-24 pCR2.1-TOPO FLAG-Bdm-1 (S
55,130,136,213D)
c m2345D
pJS-25 pCR2.1-TOPO myc-Gb
a myc-Gb in TOPO vector
pJS-26 pCPXNBn1- myc-Gb
c myc-Gb in expression vector
a. pCR2.1-TOPO vector (Invitrogen).
b. pSC-A-amp/kan vector (Stratagene).
c. Constructs subcloned into the integrating vector pCPXNBn1.
d. Constructs subcloned into the integrating vector pBC6HC1.
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phosphorylation sites
Since we demonstrated that BDM-1 is post-translationally
modiﬁed via CK2 activity, we have investigated the nature
of this modiﬁcation in more detail. Previously, QTOF mass
spectrometry was used to examine the modiﬁcations of
PhLP (Carter et al., 2004). Despite the success of our
immunoprecipitation (Fig. 1), however, it was not possible
to recover sufficient quantities of FLAG-BDM-1 for mass
spectrometry analysis. Therefore, to assess which of the
CK2 sites identiﬁed by PROSITE are phosphorylated in
physiological state of native BDM-1 protein, we engi-
neered a series of mutations with single or multiple serine
residues substituted by either alanine (unable to be tar-
geted by CK2) or aspartic acid (considered to mimic
constitutive phosphorylation; Kaufman et al., 1989). Con-
structs listed in Table 2 were transformed into Dbdm-1
spheroplasts, and isolated total protein lysates were
examined by Western blot for the migration rates of the
FLAG-BDM-1 phosphorylation mutants in comparison to
that of unmodiﬁed FLAG-BDM-1. Migration patterns were
predicted to be altered by the mutagenesis as follows: (i)
for an unmodiﬁed serine, substitution with alanine would
cause no change in migration rate but substitution by
aspartic acid would retard mobility; (ii) for a modiﬁed
serine, substitution with alanine would cause an increase
in migration rate, whereas an aspartatic acid substitution
would not change the mobility. Lastly, treatment with CIP
would remove only phosphate moieties and not alter any
mobility effects induced by aspartic acid substitution.
Single alanine substitution mutants m2A, m3A, m4A
and m5A(the numbers refer to the order of the consensus
CK2 phosphorylation sites along BDM-1 sequence, as
identiﬁed in Fig. 2) migrated at the same rate as non-
mutated FLAG-BDM-1, whereas mutant m1A exhibited
overall fastest mobility (Fig. 4A). The level of BDM-1
protein in the m2A mutant was barely detectable; there-
fore, in order to compare its migration with the subsequent
alanine mutants we increased the loading by eightfold
(Fig. 4A).
Although mobility of multiple mutants m14A, m134A
and m12345A was similarly increased compared with
Fig. 1. Absence of BDM-1 causes a loss of CPGB-1 protein.
A. N-terminal FLAG-BDM-1 complements Dbdm-1.
B. Some 25 mg of total protein probed with anti-BDM-1.
C. The recombinant proteins from total lysates immunoprecipitated
with ANTI-FLAG M2-agarose beads and eluted. The recovered
proteins separated by SDS-PAGE were probed with anti-FLAG
(Sigma). BEADS refers to ANTI-FLAG M2-agarose beads not
exposed to protein lysates but eluted with the loading buffer and
used as a control. Asterisks represent non-speciﬁc bands, the
upper arising from the beads and the lower from cross-reactivity
seen in all lysates. The arrow indicates the location of
FLAG-tagged BDM-1. The remaining lanes follow the strain key.
D. The absence of Gb subunit (CPGB-1) in Dbdm-1 lysates. Some
25 mg of total protein probed with anti-CPGB-1. Strain key: WT
(wild-type, EP155); 4B native (Dbdm1 complemented by
FLAG-BDM-1 driven by native bdm-1 promoter); Dbdm1 (bdm-1
null mutant); Dcpgb-1 (cpgb-1 null mutant, DGb); V (transformant
with vector alone); WB (WT transformant with FLAG-BDM-1 driven
by gpd promoter); 4B (Dbdm1 complemented by FLAG-BDM-1
driven by gpd promoter).
Fig. 2. Analysis of BDM-1 amino acid sequence with PROSITE
revealed putative modiﬁcations: ﬁve CK2 phosphorylation sites
(red), two PKA sites (green), ﬁve PKC sites (blue), one
N-glycosylation site (black).
Fig. 3. BDM-1 is a phosphoprotein that can be targeted by CK2
in vitro.
A. Some 35 mg of total protein lysates treated with (CIP) and
probed with anti-BDM-1. Phosphatase-treated proteins are
indicated with *.
B. Re-phosphorylation of FLAG-BDM-1 in vitro. Bound
FLAG-BDM-1 was de-phosphorylated (*) then rephosphorylated in
the presence and absence of CK2 inhibitor DMAT (I) for 2 or 22 h
as indicated. Blots probed with anti-BDM-1. Lysate key: WT
(wild-type, EP155); WB (WT transformant with FLAG-BDM-1 driven
by gpd promoter); 4B (Dbdm1 complemented by FLAG-BDM-1
driven by gpd promoter); Dbdm1 (bdm-1 null mutant).
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well as unchanged FLAG-BDM-1, double mutant m34A
migrated even faster. Nevertheless, its mobility rate
was still slightly slower than mobility of the m1A mutant
(Fig. 4B). Furthermore, treatment of whole-cell lysate
expressing m1A mutant with CIP caused an addi-
tional slight increase in migration equal to that of
de-phosphorylated FLAG-BDM-1, whereas the same
treatment of m34A lysate caused an increase in mobility
equivalent to that of m1A (Fig. 4C). Intriguingly, quadruple
alanine substitution mutant m1234A migrated with the
same rate as intact FLAG-BDM-1 while the additional
mutation at position m5 or treatment with CIP (Fig. 4C)
caused further shift in protein mobility equal to that
observed in mutant m12345A (Fig. 4C). Further CIP treat-
ment of whole-cell lysate expressing mutant m12345A
had no effect on its migration rate (Fig. 4C).
Analogous to the alanine substitution, aspartate mutant
m1D migrated with the highest rate compared with the
unaltered FLAG-BDM-1 and remaining aspartate mutants
(Fig. 4D). Single and multiple substitution mutants: m2D,
m3D, m4D, m5D, m14D, m34D and m1234D demon-
strated equal mobility, equivalent to migration rate of
intact FLAG-BDM-1 (Fig. 4D). Surprisingly, we detected
increased mobility of the triple substitution mutant m134D
in comparison to single aspartate mutants (Fig. 4D and
E). However, mutant m134D migrated with the same rate
when compared with intact FLAG-BDM-1, m134A and
m12345A (Fig. 4A). Mutants containing aspartate substi-
tutions at positions m2345D and m12345D displayed
equally decreased migration rate, slower than intact
FLAG-BDM-1 (Fig. 4D and E). Similarly to mutant m2A,
levels of FLAG-BDM-1 protein detected in lysates pre-
pared from the strain bearing an aspartate substitution
at position m2 were greatly reduced (Fig. 4D and E).
Loss of virulence of selected CK2 site mutants
All of the point mutations described above were capable
of complementing the Dbdm-1 phenotype almost entirely
(Fig. 5A) with only minor alterations in growth rate, colony
morphology, pigment and laccase production (data not
shown). However, based on analysis of migration patterns
of CK2 phosphorylation mutants described in Fig. 4, we
assessed the biological relevance of a subset of the single
and multiple mutations that represented residues most
likely target by CK2 by inoculation onto dormant chestnut
stems. Statistical analysis of data collected from at least
four (m1-5A) and as many as six (WT) independent viru-
lence assays allowed us to verify signiﬁcant differences
in virulence of a subset of the CK2 phosphorylation
site mutants (Fig. 5B and C) compared with WT and the
Fig. 4. A–E. Altered migration of BDM-1
phosphorylation site mutants. Some 25 mgo f
total protein isolated from the BDM-1
phosphorylation site mutant expressing strains
probed with anti-BDM-1. CK2
phosphorylation-site mutants (m) are labelled
with the number corresponding to a single or
combination of mutated sites, and letter A
(Ser to Ala) or D (Ser to Asp) representing
substitution type (see Table 2). CIP
de-phosphorylated lysates are loaded to the
right of each untreated sample and indicated
with ‘*’. Lysate key: WT (wild-type, EP155);
4B (Dbdm1 complemented by FLAG-BDM-1
driven by gpd promoter); Dbdm1 (bdm-1 null
mutant). For clarity, mutants in consecutive
sites have been truncated, e.g. m12345A is
labelled m1-5A.
Fig. 5. Loss of virulence of selected BDM-1 phosphorylation site mutants.
A. CK2 mutants complement Dbdm-1 with only minor phenotypic changes.
B. Representative virulence assays of CK2 mutants on dormant chestnut stems carried out for 21 days.
C. Graphical representation of the virulence assay using Tukey–Kramer HSD test. y-axis: canker size (g weight of canker outline); x-axis:
tested strain. Levels not connected by the same letter are signiﬁcantly different. Strain key: phosphorylation site mutants key as in Table 2;
WT (wild-type, EP155); 4B native (Dbdm1 complemented by FLAG-BDM-1 driven by native bdm-1 promoter); Dbdm1 (bdm-1 null mutant).
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assay also highlighted a previously undetectable impair-
ment of the FLAG-BDM-1 function that resulted in
reduced virulence.
Virulence of all tested strains expressing either single or
multiple serine/alanine or serine/aspartate substitutions
was signiﬁcantly reduced compared with WT and FLAG-
tagged BDM-1. Furthermore, all strains bearing single
or multiple alanine mutations grouped statistically with
the bdm-1 deletion mutant, suggesting that their ability
to cause disease was signiﬁcantly impaired. However, all
of the aspartate substitutions grouped together at an
intermediate level between FLAG-tagged BDM-1 and
the bdm-1 null mutant, although two aspartate mutants,
m14D and m1D, were also grouped with the bdm-1 dele-
tion strain (Fig. 5C).
Reduced accumulation of Gb in the presence of BDM-1
alanine-substituted mutants
It has been demonstrated that nascent mammalian PhLP
forms stable ternary complexes with Gb subunit and CCT
chaperonin. Furthermore, CK2-mediated phosphorylation
of PhLP promotes dissociation of PhLP/Gb dimer and
allows association with the Gg subunit (Lukov et al.,
2006). However, direct analysis of Gb stability was com-
plicated by the exhaustion of the anti-CPGB-1 used in
Fig. 1. Therefore, the C. parasitica cpgb-1 gene bearing
an N-terminal myc tag was generated by PCR using
primers listed in Table 1 and subcloned into the pCPX-
NBn1 expression vector. This construct (Table 2), veriﬁed
for sequence integrity, complemented the Dcpgb-1 phe-
notype (Fig. 6A), and coupled with the Western analysis
demonstrated that the myc-CPGB-1 was functional
(Fig. 6C and D).
Even with the tagged Gb, however, we lacked an addi-
tional selective marker to directly test the hypothesis that
the BDM-1 phosphorylation mutants would affect CPGB-1
accumulation. To overcome this obstacle, we took advan-
tage of the process of anastomosis to create stable
heterokaryon strains expressing both tagged proteins, a
process that has previously been successfully employed
in C. parasitica for complementation studies (Kasahara
et al., 2000).
Due to the possible complications of the mutants at the
putative CK2 target sites (as indicated by the migration
patterns analysis) we used the completely substituted
m12345A and m12345D variants in order to establish any
potential relationship between CK2 phosphorylation and
Gb stability. Heterokaryon strains coexpressing myc-Gb/
m12345A and myc-Gb/m12345D were ﬁrst veriﬁed for
presence of both genes by PCR using genomic DNA as
template, then observed for distinct phenotypes in com-
parison to myc-Gb expressed with non-mutated BDM-1.
As with the expression of the BDM-1 mutants in the
Dbdm-1 background (Fig. 5A), the differences in pheno-
type were modest (Fig. 6A). We noted a slight increase
in white aerial mycelium development in the strain
Fig. 6. Differences in stability of Gb and
BDM-1 proteins in presence of coexpressed
BDM-1 phosphorylation mutants.
A. N-terminal myc-Gb is fully functional and
complements phenotypes of Dcpgb-1.
B. Minor phenotypic differences in
heterokaryons coexpressing myc-Gb and
mutated BDM-1. The edge of growing colony
revealed changes in the morphology and
pigmentation of aerial hyphae between
strains: Dcpgb-1, myc-Gb, myc-Gb/m12345A
and myc-Gb/m12345D (11¥ magniﬁcation).
C. Levels of myc-Gb protein compared
between myc-Gb, myc-Gb/m12345A and
myc-Gb/m12345D BDM-1 strains. Blot probed
with anti-myc.
D. Levels of BDM-1 protein compared
between myc-Gb, myc-Gb/m12345A and
myc-Gb/m12345D strains. Blot probed with
anti-BDM-1. Strain and lysate key: Dcpgb-1
(cpgb-1 null mutant, DGb); myc-Gb (Dcpgb-1
complemented by N-terminally tagged
myc-Gb coexpressing unmodiﬁed BDM-1);
myc-Gb/m12345A (heterokaryon strain
coexpressing myc-Gb and mutant m12345A);
myc-Gb/m12345D (heterokaryon strain
coexpressing myc-Gb and mutant m12345D).
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CPGB-1 and, contrastingly, the periphery of the strain
coexpressing the aspartate-substituted BDM-1 and myc-
CPGB-1 appeared to be reduced in aerial mycelium and
with greater production of orange pigment (Fig. 6B).
Western blot analysis of heterokaryon strains revealed
differences in the stability of myc-Gb protein in the pres-
ence of BDM-1 phosphorylation mutants. Coexpression of
m12345A caused reduced accumulation of myc-Gb by
eightfold compared with m12345D, whereas only a slight
decrease of myc-Gb protein was observed in presence
of m12345D, compared with unmodiﬁed FLAG-BDM-1
(Fig. 6C). To ensure the reproducibility, levels of Gb
protein were assessed for three different sets of heter-
okaryons coexpressing myc-Gb and mutated or
unchanged BDM-1. Expression of mutated and unmodi-
ﬁed FLAG-BDM-1 in heterokaryon strains was conﬁrmed
by detection with anti-BDM-1 (Fig. 6D). Consistent with
accumulation of myc-Gb, level of mutated m12345A
protein was approximately four- to eightfold lower than
levels of m12345D.
Discussion
Perturbation of heterotrimeric G-protein signalling has
been shown to affect virulence, pigmentation and sporu-
lation of fungal pathogens (Lengeler et al., 2000). Previ-
ous studies of C. parasitica have identiﬁed components
of G-protein signalling, including BDM-1, a PhLP, and
CPGB-1, the Gb-subunit. Elimination of either protein
reduces virulence, pigmentation and sporulation in an
almost identical manner (Kasahara et al., 2000). Further-
more, infection of C. parasitica with virulence-attenuating
dsRNA viruses (hypoviruses) compromises G-protein sig-
nalling and causes changes in virulence and phenotype,
with aspects that resemble those of the BDM-1 and Gb
deletion strains (Dawe and Nuss, 2001; Dawe et al.,
2004).
In this study, we have explored the nature of a post-
translational modiﬁcation of BDM-1 and its role in the
stability of Gb-subunit in the plant pathogen C. para-
sitica. Although identiﬁed and conﬁrmed to inﬂuence
G-protein signalling in S. cerevisiae (Flanary et al.,
2000), A. nidulans (Seo and Yu, 2006) and C. parasitica
(Kasahara et al., 2000), no further information has been
available concerning the exact role for PhLPs in fungal
signalling pathways. We can now conﬁrm the functional
association of BDM-1 and Gb since the levels of Gb
protein are undetectable in the absence of BDM-1
(Fig. 1). A requirement of BDM-1 for Gb stability explains
the nearly identical phenotypes of BDM-1 and Gb
subunit knockouts and suggests that the function of
BDM-1 may correlate with that noted for mammalian
PhLP (Lukov et al., 2005).
Evidence from mammalian systems has demonstrated
that PhLPs undergo phosphorylation by CK2 that is
essential for their function (Humrich et al., 2003). Our
observation that phosphatase-treated BDM-1 migrates
faster (Fig. 3A) demonstrated that the native state of
BDM-1 also involves phosphorylation at one or more
sites. Most importantly, it was possible to restore migra-
tion of BDM-1 to the pretreatment level by further incuba-
tion with whole-cell lysates. However, this process could
be inhibited by the addition of a speciﬁc inhibitor of CK2
(Fig. 3B). Coupled with the observation that PhLPs have
been found in all branches of eukarya from fungi to
humans (Willardson and Howlett, 2007), this suggests
that the CK2-mediated modulation of PhLPs is a con-
served process.
To determine which of the presumed CK2 phosphory-
lation sites are biologically relevant, we engineered a
series of FLAG-BDM-1 constructs bearing mutations
that either block (Ser to Ala) or mimic (Ser to Asp) CK2-
mediated phosphorylation at single or multiple sites.
Western blot analysis of migration patterns of the BDM-1
phosphorylation mutants (Fig. 4) allowed us to hypoth-
esize which residues are most likely targeted by CK2
in vivo.
Mutants with Ser to Ala substitutions m1A, m34A,
m14A, m134A and m12345A showed overall increased
mobility in comparison to intact FLAG-BDM-1 (Fig. 4A),
indicating that some of these residues are normally
phosphorylated. Mutant m1A exhibited the fastest overall
migration rate (Fig. 4B). Further shift in migration equal to
that of de-phosphorylated 4B was noted after its treatment
with CIP (Fig. 4C). Considering the above observations,
the fact that BDM-1 could be a target for PKA and/or PKC
activity (Fig. 2), and that CK2 can act in a in hierarchical
manner (Hrubey and Roach, 1990), we concluded that
position m1 is most likely modiﬁed by CK2. Treatment with
CIP manifested an increased mobility, probably due to
removal of all covalently bound phosphates that resulted
from the activity of other kinases.
Although single mutants m3A and m4A migrated simi-
larly to unmodiﬁed FLAG-BDM-1, variant m34A exhibited
slightly increased migration. Thus, we suspect that either
position m3 or m4 might be targeted by CK2 as well.
Bearing in mind that mutants m14A, m134A and
m12345A migrated with the same rate, we suggest that
CK2 sites m1 and m4 are most likely phosphorylated
while sites m2, m3 and m5 are not (Fig. 4A and B).
It has been reported that phosphorylation within the
CK2 sites can be primed in a hierarchical fashion by
previously phosphorylated residues (Roach, 1991; Salvi
et al., 2009). Therefore, we suggest that introduction of
the phosphate at position m1 may inﬂuence the subse-
quent phosphorylation at remaining sites. The phenom-
enon of hierarchical phosphorylation within CK2 sites may
Phosphorylation of a fungal phosducin-like protein 855
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 76, 848–860serve as an explanation to the observation that the migra-
tion rate of variant m1A (in which substitution of serine
by alanine inhibits additional phosphorylation at m4) is
faster than predicted (Fig. 4B). Consequently, even
though mutant m34A (presumably phosphorylated at
position m1) migrates slightly slower than m1A (possibly
due to absence of phosphate at position m4), upon treat-
ment with CIP its migration rate is equal to that of m1A
(Fig. 4C). Accordingly, mutants m14A, m134A and
m12345A showed decreased migration rate compared
with m34A possibly due to lack of phosphorylation at
positions m1 and m4 (Fig. 4B and C). The concentration
of multiple serine residues around m3 and m4 sites, along
with the presence of multiple acidic residues in this region,
could stimulate creation of new phosphoacceptor sites as
demonstrated by Salvi et al. (2009) and Hrubey and
Roach (1990).
Unexpectedly, migration of mutant m1234A was equal
to that of unmodiﬁed FLAG-BDM-1 (Fig. 4A) and could be
restored to migration rate of m12345A by treatment with
CIP (Fig. 4C).Apossible explanation of this observation is
that simultaneous presence of alanine residues at sites
m1 through 4 eliminates CK2 activity at these positions,
and consequently site m5 becomes a next available target
for non-hierarchical phosphorylation by CK2 or other
kinase, even though the single m5A substitution sug-
gested that m5 is not a usual target.
Comparison of migration patterns of Ser toAsp variants
conﬁrmed that sites m2 and m5 are not targeted by CK2
in vivo since their mobility was retarded (Fig. 4D). Inter-
estingly, mobility of mutant m134D was faster than
unmodiﬁed BDM-1 but equal to that of m134A contradict-
ing our conclusion that site m3 is not targeted by CK2
(Fig. 4A and E). One explanation for this inconsistency is
that addition of aspartate residues at sites m3 and m4
mimics phosphorylation at two mutually exclusive sites,
and subsequently impairs the activity of another kinase as
described for hormone-sensitive lipase (Yeaman, 1990).
Since the role of serine at position m3 in hierarchical
phosphorylation is not clear, it is possible that the phos-
phoserine itself may be involved in recognition at the
active site of a secondary kinase as suggested by Roach
(1991). Furthermore, predicted PKA and PKC phosphoy-
lation sites reside within 25-amino-acid region upstream
of the m3 and 35-amino-acid stretch downstream of the
m4 phosphorylation sites (Fig. 2). Perhaps, despite the
introduction of aspartate residues, which are considered
positive determinants for CK2 phosphorylation, modiﬁed
FLAG-BDM-1 becomes refractory to CK2 activity, as
reported for the M8 protein of Drosophila melanogaster
(Karandikar et al., 2004).
We conclude that mutagenesis of FLAG-BDM-1 most
likely altered its usual hierarchical phosphorylation
scheme. Presence of the phosphate, but not the acidic
substitute, may be crucial for kinase activity even without
the phosphate itself participating in kinase-substrate inter-
action (Roach, 1991). Lastly, this may also indicate a
potential role of an as-yet unidentiﬁed phosphatase par-
ticipating in this scheme. Although mammalian PhLP is
phosphorylated by CK2 at three of the ﬁve predicted sites
(Lukov et al., 2006), our current evidence indicates that
CK2-mediated phosphorylation of BDM-1 in vivo may
only occur at two sites, m1 and m4. Despite numerous
Western blots performed for this study, we have never
been able to observe a band detectable with BDM-1 anti-
serum that migrates similar to BDM-1 dephosphorylated
in vitro. While not direct evidence, this suggests that
BDM-1 is predominantly in a phosphorylated state and is
supported by the observation that all of mammalian PhLP
was phosphorylated by CK2 within 30 min of translation
(Lukov et al., 2006).
Fungal virulence is likely a complex interaction that
involves a wide array of physiological and molecular
determinants. Ongoing molecular studies of fungal viru-
lence constantly uncover new genes and factors contrib-
uting to the overall pathogenicity of different fungi (Odds
et al., 2001). It has been previously established that
BDM-1 plays a positive role in regulation of virulence of C.
parasitica (Kasahara et al., 2000). However, while grown
on PDA, none of the substitutions exhibited signiﬁcant
effect on colony phenotype. Based on our interpretation of
the gel electropheisis data, we selected a series of strains
that expressed mutations at positions m1, m4, m14 and
m12345 and compared their phenotypes in greater detail.
As noted, these mutations appeared to complement the
Dbdm-1 phenotype on rich medium (Fig. 5A).
When tested for virulence, however, all strains bearing
these single or multiple alanine mutations were signiﬁ-
cantlyimpairedintheirabilitytocausedisease,whileallthe
aspartatesubstitutionswerevirulentatalevelintermediate
between FLAG-tagged BDM-1 and the bdm-1 null mutant
(Fig. 5B and C). This general trend suggests that the
substitution with alanine has a larger impact on virulence
than substitution with aspartic acid and supports the
hypothesisthatCK2phosphorylationofBDM-1isfunction-
ally relevant, although asparte residues in these positions
are not able to fully mimic the proper physiological state.
While the application of the phosphate group is critical for
function under the more demanding condition of the
virulence assay, removal of the phosphate likely plays an
as-yet unidentiﬁed role and other mechanisms may com-
pensateforpartialfunctioninamannerthatprovidesforan
essentially unaltered phenotype on rich growth medium.
Human PhLP-1 forms functional ternary complexes
with Gb subunits and CCT complex enabling downs-
tream transduction of the signal, whereas disruption of
PhLP-1 blocks the signalling cascade and prevents the
re-association of the Gabg heterotrimer (Lukov et al.,
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that absence of phosphorylation of mammalian PhLP at
two or three consecutive serines signiﬁcantly reduced Gb
or Gg subunit that was detectable by immunoprecipitation
(Lukov et al., 2005).
By coexpressing tagged BDM-1 and CPGB-1 in a fused
heterokaryon strain and using a serial dilution strategy, we
have estimated that the accumulation of non-mutated
BDM-1 and the aspartate-subsituted form are very similar
(with a maximum of a twofold difference). However, the
alanine-substituted mutant caused an eightfold reduction
of both BDM-1 and CPGB-1 proteins (Fig. 6C and D).
Therefore, phosphorylation of the PhLP BDM-1 by CK2
is important for Gb stability. However, we cannot discern
whether this is due to a reduced ability of the mutants to
interact with CPGB-1, or by impairing the stability of the
BDM-1 itself. This latter point may relate to the levels of
BDM-1 accumulation in mutants m2A and m2D. Numer-
ous Western blot analyses of six m2A and four m2D
transformants consistently revealed an eightfold decrease
in BDM-1 levels. Considering that nearly all cellular func-
tions have been linked to CK2 activity (Pinna andAllende,
2009), and that CK2 plays central regulatory role in gene
expression and protein synthesis/degradation (Pinna
and Allende, 2009), we suggest that in addition to its
biological relevance in virulence and Gb stability, the CK2-
dependent phosphorylation cycle of BDM-1 participates
in modulating turnover of this protein.
The results presented above provide evidence for the
requirement of CK2-mediated phosphorylation of BDM-1,
although our current data do not allow us to state with
certainty the precise phosphorylation pattern. However,
we propose that, in its nascent state, BDM-1 undergoes
phosphorylation by CK2, possibly at positions m1 and
m4, in a hierarchical manner with m1 being targeted ﬁrst.
Once phosphorylated, we predict that BDM-1 is able to
encourage the formation of a functional Gbg dimer, pre-
sumably in the presence of a fungal CCT complex. This
would then be followed by association with the Gg subunit.
Substitution of serine residues by alanine at positions m1
and m4 prevents phosporylation at those sites, desta-
bilizes the process such that the signalling pathway
becomes impaired to a level that is unable to fully support
virulence, but does not greatly impact vegetative growth.
In the complete absence of BDM-1, the assembly fails
and our data would suggest that this then leads to deg-
radation of the Gb subunit. This model is consistent with
a role for BDM-1 that is analogous to that identiﬁed for
PhLP-1 in mammalian systems, in which CK2 phos-
phorylation was required for Gbg assembly (Lukov et al.,
2006; Willardson and Howlett, 2007) and accumulation of
Gbg complex was compromised in cells depleted for
PhLP-1 (Lukov et al., 2005). This suggests an evolution-
arily conserved mechanism for Gbg regulation.
Experimental procedures
Fungal strains and growth conditions
Cryphonectria parasitica EP155 (ATCC 38755), Dcpgb-1
(Kasahara and Nuss, 1997), Dbdm-1 (Kasahara et al., 2000)
and all other strains generated for this study were maintained
on potato dextrose agar (PDA; Difco) at room temperature
(22–24°C) and 12 h light/dark illumination of approximately
1100 lux. Growth in liquid cultures was conducted at room
temperature in potato dextrose broth (PDB; Difco) with light
conditions as described above. For protein preparations,
liquid cultures were grown for 3–4 days in PDB, homogenized
with a Polytron PT1600E (Kinematica AG), diluted with an
equal volume of fresh PDB and grown an additional 2–3
days prior to harvesting by ﬁltration by Miracloth (EMD
Biosciences). Heterokaryons were created by inoculating
PDAplates with plugs of the desired precursor strains, placed
approximately 2–3 mm apart.After 3 days, plugs of mycelium
were recovered from the fused region and maintained on
PDA.
Protein extracts and Western blots
Protein lysates were obtained from liquid cultures essentially
according to Parsley et al. (2003), but using a modiﬁed
Protein Extraction Buffer [100 mM Tris (pH 8.0), 1 mM EDTA,
150 mM NaCl, 1% Triton X-100]. Samples were run on
NuPAGE 10 or 12% Bis-Tris Gels (Invitrogen) in MOPS buffer
and probed with appropriate antibodies. Images were
acquired with HRP chemiluminescent detection reagents
(Bio-Rad) on a Chemidoc XRS imaging system (Bio-Rad).
Antibodies
Anti-BDM1 antiserum was generated in rabbits by Strategic
Biosolutions (now Strategic Diagnostics) using puriﬁed
BDM-1 isolated from E. coli expressing a 6-His tagged fusion
protein (Qiagen QIAexpress system). The fusion protein was
recovered from cell lysates using a Ni
2+ charged HiTraP
column (Amersham Biosciences). The BDM-1 binding portion
was recovered from serum by passing over puriﬁed BDM-1
attached to a covalently NHS-activated Hi-trap column
(Amersham). For all Western blots described below, this puri-
ﬁed antiserum was used at 1 : 2500 dilution.Anti-Gb (Parsley
et al., 2003) was kindly provided by Donald Nuss (University
of Maryland Biotechnology Institute). For detection of myc
tagged constructs a 1 : 1000 dilution of anti-myc –HRP
(Invitrogen) antibody was used, followed by a 1 : 000 HRP-
conjugated anti-mouse secondary antibody (Bio-Rad).
N-terminal tagging, mutagenesis and
immunoprecipitation
The coding sequence for the FLAG (DYKDDDDK) or myc
(QGKLISQQDL) epitopes was incorporated into 5′ primers for
bdm-1 or cpgb-1, respectively, following the start codon while
the reverse primers contained either a HindIII or XbaI restric-
tion site. All primer sequences are detailed in Table 1. The
ampliﬁed products were cloned into pCR2.1-TOPO vector
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sequenced to verify their integrity, resulting in plasmids
pJS-2, pJS-2X and pJS-25 (Table 2). Digestion of plasmids
pJS-2 (NotI and HindIII) and pJS-2X (NotI and XbaI) liberated
fragments containing FLAG-tagged bdm-1, which were
then subcloned into the same restriction sites of C. parasitica
expression vectors pCPX-NBn1 (containing gpd promoter)
and pBC6HC1 (containing native bdm-1 promoter) resulting
in plasmids pJS-3 and pJS-3X respectively. Excised from
plasmid pJS-21 by restriction digest with NotI and HindIII,
myc-tagged cpgb-1 was subcloned into the expression vector
pCPX-NBn1 resulting in plasmid pJS-26. Both expression
vectors pCPX-NBn1 and pBC6HC1 contained a benomyl
resistance gene (ben
r) for selectivity.
Mutagenesis of FLAG-BDM-1 was initially performed
using pJS-3 as template according to the Quick Change
Site Directed Mutagenesis Kit (Stratagene) and veriﬁed by
sequencing. Mutated bdm-1 sequences were subcloned into
the expression vector as described above and followed by
transformation of the Dbdm-1 spheroplasts using the method
of Churchill et al. (1990). For subsequent multiple mutants we
used already existing constructs as their templates and
added desired modiﬁcations. Single, benomyl resistant colo-
nies were isolated from asexual spores to ensure nuclear
homogeneity.
Fusion proteins contained in 35 mg of total protein
lystates were bound to 20 ml of ANTI-FLAG M2-agarose
beads (Sigma) for 2 h at room temperature, washed and
eluted with 2¥ LDS buffer (Invitrogen) or processed for
re-phosphorylation. Samples were run on NuPAGE 10 or
12% Bis-Tris Gels (Invitrogen) in MOPS buffer and probed
with anti-BDM-1 serum followed by 1 : 2500 HRP-conjugated
anti-rabbit secondary antibody (Bio-Rad).
De-phosphorylation and Re-phosphorylation assays
Some 35 mg of clear protein lysates was incubated for 30 min
at 37°C with 20 000 units of CIP (Invitrogen) then immuno-
precipitated with 20 ml of ANTI-FLAG M2-agarose beads.
De-phosphorylated proteins were re-phosphorylated by addi-
tion of equal amounts of WT (EP155) protein extracts in
presence of 1 mM ATP (Sigma), 100 mM sodium orthovana-
date (Sigma) to inhibit residual CIP activity and 20 mM spe-
ciﬁc Casein Kinase II (CK2) inhibitor 2-dimethylamino-4, 5, 6,
7-tetrabromo-1H-benzimidazole (DMAT; EMD Biosciences)
where indicated. The reaction was performed at room tem-
perature in the dark and protein eluted with 2¥ LDS buffer
followed by separation on NuPAGE 10% Bis-Tris Gels (Invit-
rogen) in MOPS buffer. Protein detection was carried out
as previously described.
Virulence assay of BDM-1 phosphorylation mutants
The virulence assays were performed essentially as
described by Jaynes and Elliston (1980). Dormant chestnut
stems (kindly provided by W. MacDonald, West Virginia
University) stored at -20°C were defrosted overnight and
thoroughly cleaned with 75% ethanol. Wounds in 5 mm diam-
eter removing the bark were made using a sterile cork borer.
Fresh mycelial plugs were placed into the wounds and
wrapped with paraﬁlm to prevent desiccation. Paraﬁlm was
removed after 3 days once the plugs were well established.
The experiment was carried out for a total of 21 days and
relative canker size was measured by the simple method of
tracing the outline of the canker edge using a piece of para-
ﬁlm and weighing the resulting cut-outs. Statistical analysis
of virulence data was conducted using a Tukey–Kramer HSD
(honestly signiﬁcant difference) test, a single-step statistical
analysis that compares all possible pairs of means, and
identiﬁes which means are signiﬁcantly different from one
another.
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